These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16105868)

  • 1. Beneficial haemodynamic and renal sodium handling effects of combined midodrine and octreotide treatment in a cirrhotic patient with large hepatic hydrothorax and mild ascites.
    Kalambokis G; Fotopoulos A; Economou M; Tsianos EV
    Nephrol Dial Transplant; 2005 Nov; 20(11):2583. PubMed ID: 16105868
    [No Abstract]   [Full Text] [Related]  

  • 2. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F; Pantea L; Sniderman K
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications.
    Karwa R; Woodis CB
    Ann Pharmacother; 2009 Apr; 43(4):692-9. PubMed ID: 19299324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.
    Angeli P; Volpin R; Gerunda G; Craighero R; Roner P; Merenda R; Amodio P; Sticca A; Caregaro L; Maffei-Faccioli A; Gatta A
    Hepatology; 1999 Jun; 29(6):1690-7. PubMed ID: 10347109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Al Bokharhii J; Pappas C; Katsaraki A; Tsianos EV
    Am J Gastroenterol; 2005 Apr; 100(4):879-85. PubMed ID: 15784036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a 7-day treatment with midodrine in non-azotemic cirrhotic patients with and without ascites.
    Kalambokis G; Fotopoulos A; Economou M; Pappas K; Tsianos EV
    J Hepatol; 2007 Feb; 46(2):213-21. PubMed ID: 17156883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.
    Singh V; Dhungana SP; Singh B; Vijayverghia R; Nain CK; Sharma N; Bhalla A; Gupta PK
    J Hepatol; 2012 Feb; 56(2):348-54. PubMed ID: 21749847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midodrine and clonidine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.
    Singh V; Singh A; Singh B; Vijayvergiya R; Sharma N; Ghai A; Bhalla A
    Am J Gastroenterol; 2013 Apr; 108(4):560-7. PubMed ID: 23419385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination treatment with octreotide, midodrine, and albumin improves survival in patients with type 1 and type 2 hepatorenal syndrome.
    Skagen C; Einstein M; Lucey MR; Said A
    J Clin Gastroenterol; 2009 Aug; 43(7):680-5. PubMed ID: 19238094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hepatic hydrothorax with vasoconstrictor drugs.
    Kalambokis G; Tsianos EV
    Scand J Gastroenterol; 2007 Apr; 42(4):534. PubMed ID: 17454867
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vasoconstrictors in the treatment of hepatorenal syndrome].
    Ortega R; Calahorra B; Ginès P
    Nefrologia; 2002; 22 Suppl 5():56-61. PubMed ID: 12107919
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic hydrothorax in the absence of ascites in a child with autoimmune hepatitis: Successful management with octreotide and pleurodesis.
    Sıra MM; Sıra AM; Behairy Bel-S; Bakır RM; El-Hagaly MA
    Turk J Gastroenterol; 2013; 24(2):174-83. PubMed ID: 23934468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study.
    Appenrodt B; Wolf A; Grünhage F; Trebicka J; Schepke M; Rabe C; Lammert F; Sauerbruch T; Heller J
    Liver Int; 2008 Aug; 28(7):1019-25. PubMed ID: 18410283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study.
    Tandon P; Tsuyuki RT; Mitchell L; Hoskinson M; Ma MM; Wong WW; Mason AL; Gutfreund K; Bain VG
    Liver Int; 2009 Feb; 29(2):169-74. PubMed ID: 18492024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midodrine and tolvaptan in patients with cirrhosis and refractory or recurrent ascites: a randomised pilot study.
    Rai N; Singh B; Singh A; Vijayvergiya R; Sharma N; Bhalla A; Singh V
    Liver Int; 2017 Mar; 37(3):406-414. PubMed ID: 27614145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide in the treatment of refractory ascites of cirrhosis.
    Kalambokis G; Fotopoulos A; Economou M; Tsianos EV
    Scand J Gastroenterol; 2006 Jan; 41(1):118-21. PubMed ID: 16373285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hepatic hydrothorax with terlipressin in a cirrhotic patient.
    Ibrisim D; Cakaloglu Y; Akyuz F; Karadag A; Ozdil S; Besisik F; Mungan Z; Okten A
    Scand J Gastroenterol; 2006 Jul; 41(7):862-5. PubMed ID: 16785202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical study on the therapeutic role of midodrine in non azotemic cirrhotic patients with tense ascites: a double-blind, placebo-controlled, randomized trial.
    Ali A; Farid S; Amin M; Kassem M; Al-Garem N
    Hepatogastroenterology; 2014 Oct; 61(135):1915-24. PubMed ID: 25713888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide in the treatment of refractory ascites of cirrhosis.
    Leong RW; Jeffrey GP
    Scand J Gastroenterol; 2006 Jun; 41(6):763; author reply 764. PubMed ID: 16716981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.